SUBSCRIBE
SUBSCRIBE

Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS
Business negotiation and cooperation vector concept. Symbol of a deal, handshake, success. Minimal design eps10 illustration.
Weight loss
GSK goes beyond weight-loss with $1B buyout of Chinese siRNA specialist
With Siran Biotechnology under its fold, GSK will have access to a long-acting siRNA therapy that could induce weight loss while preserving lean mass, in addition to addressing other weight-related comorbidities.
May 7, 2026
 · 
2 min read
 · 
Tristan Manalac
Insights
Fibrosis, IPF and the search for better therapies
In this episode of Denatured, you’ll be hearing from Georg Vo Beiske, CEO of Tribune Therapeutics and Jonas Hallén, co-founder and Chief Medical Officer of Calluna Pharma. We dive into IPF and fibrosis challenges, unpacking treatment hurdles, emerging targets, unmet needs and expansion paths beyond the lung.
May 7, 2026
 · 
1 min read
 · 
Jennifer C. Smith-Parker
Illustration of panel interview showing group of employees at table interviewing job candidate
Career Advice
Winning the room: how to ace panel interviews
Panel interviews can play a major role in getting jobs. Two career coaches discuss what to do before and during the interview, including identifying how to differentiate yourself, engaging in true conversations and not overlooking a key panel member.
May 7, 2026
 · 
5 min read
 · 
Angela Gabriel
Contemporary art collage. employee mowing forward to success, stepping ladder of professional growth. Concept of business.
Job Trends
Increased capital boosts biotech R&D job postings, employment
Biotech R&D job postings live on BioSpace rose for the fourth straight month in April, and a CBRE report shared similar findings for employment. The head of CBRE’s U.S. life sciences practice discusses what’s behind the growth and the current job market.
May 7, 2026
 · 
4 min read
 · 
Angela Gabriel
Pictured: Office building science collage
Career Advice
The top 12 companies hiring in biopharma now
Looking for a biopharma job? Check out the BioSpace list of 12 top companies hiring life sciences professionals like you.
May 7, 2026
 · 
1 min read
 · 
Angela Gabriel
Job Trends
2026 Q1 Job Market Report: Job postings picked up as quarter progressed
Opportunities increased by the end of the first quarter, according to BioSpace data.
May 7, 2026
 · 
4 min read
 · 
Angela Gabriel
Illustration of a ferris wheel spinning out of control and people flying off
Editorial
3 top FDA, CDC roles filled by 15 different people in less than 18 months
The Department of Health and Human Services is spinning its wheels, unable to establish steady leadership at three major divisions—the CDC and the FDA’s two primary review units.
May 7, 2026
 · 
5 min read
 · 
Jef Akst
Community expansion. Collaboration, of new members. Cooperate on project development. Find like-minded people, join the team. Spread influence and power.
Manufacturing
Amgen, Sanofi commit nearly $600M to North American expansions
Sanofi’s investment will support a Canadian site’s efforts to apply AI to drug production, while Amgen has unveiled the second expansion of its Puerto Rico plant in quick succession.
May 6, 2026
 · 
2 min read
 · 
Nick Paul Taylor
FDA
Unforced errors flummox HHS’ radical transparency bid—again
Robert F. Kennedy Jr.’s health department has consistently touted radical transparency as being key to its mission. Recent instances—the FDA’s decision not to disclose the recipients of three Commissioner’s National Priority Vouchers and FDA and CDC choices not to publish vaccine-related papers—call this intent into question.
May 6, 2026
 · 
6 min read
 · 
Heather McKenzie
Load More
Visit website
Email Us
IN THE PRESS
Press Releases
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
June 2, 2025
 · 
4 min read
BioMidwest
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 8, 2022
 · 
4 min read
Business
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 2, 2020
 · 
4 min read
JOBS